Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Clinical Colorectal Cancer|October 1, 2016
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term OutcomeViviane Hess, Ralph Winterhalder, Roger von Moos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2013
Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomasFlavio Forrer, Catharina Oechslin-Oberholzer, Benedetta Campana, et al.
Microbiology (Reading, England)|April 1, 2008
The acidic, glutamine-rich Mpn474 protein of Mycoplasma pneumoniae is surface exposed and covers the complete cellJan Hegermann, Sven Halbedel, Roger Dumke, et al.
BMC Cancer|October 1, 2014
Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort studyBenjamin Kasenda, Annatina Bass, Dieter Koeberle, et al.
Neoplasia (New York, N.Y.)|May 22, 2004
Amplification of SKI is a prognostic marker in early colorectal cancerMartin Buess, Luigi Terracciano, Jürgen Reuter, et al.
Oncology Reports|June 10, 2005
Prognostic and predictive relevance of microsatellite instability in colorectal cancerIana Storojeva, Jean-Louis Boulay, Karl Heinimann, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancerMartin Buess, Luigi Terracciano, Jurgen Reuter, et al.
International Journal of Cancer|February 14, 2003
SMAD7 is a prognostic marker in patients with colorectal cancerJean-Louis Boulay, Gabriele Mild, Adam Lowy, et al.
Oncology|July 15, 2005
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancerIana Storojeva, Jean-Louis Boulay, Pierluigi Ballabeni, et al.
Therapeutic Advances in Medical Oncology|January 15, 2019
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scoresPiera Gargiulo, Daniel Dietrich, Richard Herrmann, et al.
Pageof 9